These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 33722754)
1. Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review. Kirchler C; Husar-Memmer E; Rappersberger K; Thaler K; Fritsch-Stork R Autoimmun Rev; 2021 May; 20(5):102794. PubMed ID: 33722754 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406 [TBL] [Abstract][Full Text] [Related]
3. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Braunstein I; Klein R; Okawa J; Werth VP Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767 [TBL] [Abstract][Full Text] [Related]
4. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus. Cho YM; Furie R Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249 [TBL] [Abstract][Full Text] [Related]
5. New insights into the progression from cutaneous lupus to systemic lupus erythematosus. Zhou W; Wu H; Zhao M; Lu Q Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644 [TBL] [Abstract][Full Text] [Related]
6. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study. Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306 [TBL] [Abstract][Full Text] [Related]
7. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study. Shams-Eldin AN; Yafasova A; Faurschou M; Schou M; Sun G; Gislason GH; Torp-Pedersen C; Fosbøl EL; Køber L; Butt JH Clin Rheumatol; 2022 Nov; 41(11):3525-3536. PubMed ID: 35907102 [TBL] [Abstract][Full Text] [Related]
8. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients. Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325 [TBL] [Abstract][Full Text] [Related]
9. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study. Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159 [TBL] [Abstract][Full Text] [Related]
10. Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus. Mohan S; Barsalou J; Bradley TJ; Slorach C; Reynolds JA; Hasni S; Thompson B; Ng L; Levy D; Silverman E; Kaplan MJ Arthritis Rheumatol; 2015 May; 67(8):2257-62. PubMed ID: 25891295 [TBL] [Abstract][Full Text] [Related]
11. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study. Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Grönhagen CM; Fored CM; Granath F; Nyberg F Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972 [TBL] [Abstract][Full Text] [Related]
13. Black patients with cutaneous lupus are associated with positive family history of cutaneous lupus and systemic lupus. Keum H; Brown LS; Chong BF Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36600582 [TBL] [Abstract][Full Text] [Related]
14. Role of neutrophils in cutaneous lupus erythematosus. Yamamoto T J Dermatol; 2024 Feb; 51(2):180-184. PubMed ID: 38009863 [TBL] [Abstract][Full Text] [Related]
15. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Sarkar MK; Hile GA; Tsoi LC; Xing X; Liu J; Liang Y; Berthier CC; Swindell WR; Patrick MT; Shao S; Tsou PS; Uppala R; Beamer MA; Srivastava A; Bielas SL; Harms PW; Getsios S; Elder JT; Voorhees JJ; Gudjonsson JE; Kahlenberg JM Ann Rheum Dis; 2018 Nov; 77(11):1653-1664. PubMed ID: 30021804 [TBL] [Abstract][Full Text] [Related]
17. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus. Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease in systemic lupus erythematosus: an update. Liu Y; Kaplan MJ Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498 [TBL] [Abstract][Full Text] [Related]
19. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus. Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760 [TBL] [Abstract][Full Text] [Related]
20. Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis. Guo LN; Nambudiri VE Clin Rheumatol; 2021 Feb; 40(2):491-499. PubMed ID: 32623651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]